Elevated DLK1 expression has been documented across a spectrum of cancers affecting various organ systems, including the endocrine system, gastrointestinal tract, lungs, liver, kidneys, brain, breast, sarcomas, and both pediatric and adult blood cancers. Here, DLK1 is linked to cancer.